最新精品麻豆一区二区,久久国产精品99精品国产福利 ,亚洲国产精品乱码一区二区,亚洲精品欧洲久久婷婷99,亚洲精品一区二区在线,91孕妇精品一区二区三区,久久99精品九九九久久婷婷,最新精品伦理一区二区

Home> Updates

Bayer, medical body sign deal to boost innovation in public hospitals

(chinadaily.com.cn) Updated: 2021-09-05

German pharmaceutical giant Bayer AG signed a deal with the Beijing branch of the Chinese Medical Association on a research-based hospital room project to promote the innovative development of Chinese public hospitals.

The two parties signed an agreement during the ongoing China International Fair for Trade in Services. According to the agreement, they will jointly launch a research project to promote the construction of research-based patient rooms in Beijing.

A research patient room is a place where medical workers conduct clinical research on drugs and medical devices, and observe the clinical application of new biomedical technologies in hospitals with conditions. It is an important medical resource and technological infrastructure.

The research project takes public hospitals that have already begun research-based ward construction as the research object, sorts out and analyzes the implementation status of research and construction, summarizes the typical experience of pilot hospitals, and further explores new models of research-based ward construction.

Feng Guosheng, head of the Beijing branch of the Chinese Medical Association, said: "The improvement of medical system is closely related to medical scientific research. This research project, which is under the guidance of Beijing Municipal Health Commission and Beijing Municipal Science & Technology Commission, is beneficial to improving hospitals' clinical research quality, strengthening their innovative abilities, and promoting the construction of research-based patient rooms."

"Our cooperation with Bayer is an effective attempt of joining efforts from academic institutions and enterprises to promote innovative clinical research," he said.

This year's CIFTIS has included the theme of healthcare service for the first time. Currently, the world is facing huge public health challenges, and medical and health-related topics have attracted great attention.

According to Bayer, during this year's CIFTIS, it will demonstrate its innovative drugs in diabetes, cardiovascular diseases and cancer.

Zhou Xiaolan, executive vice-president & president of Bayer Pharmaceuticals China, said: "The CIFTIS is an important window for China's opening-up. It offers an international platform for multinational corporations, such as Bayer, to present themselves and cooperate with other parties. It is also a crucial channel for us to learn more about local medical needs."

"Taking advantage of the fair, Bayer hope to deepen the communication and cooperation with our Chinese partners, give full play to our advantage in healthcare, constantly bring more innovative products to Chinese patients, and contribute to the implementation of crucial national strategies such as 'Healthy China'," she said.


主站蜘蛛池模板: 精品久久久久久无码中文字幕一区 | 国产精品JIZZ在线观看无码 | 大陆极品少妇内射AAAAA 精品国产一区二区三区京东影业 | 久久国产精品成人免费古装 | 男女超爽视频免费播放 | 亚洲精品v日韩精品 | 久久久SSS国产澳门 | 丰满少妇高潮惨叫久久久一 | 波多野结衣爽到高潮大喷 | 亚洲熟女少妇一区二区 | 亚洲AV无码国产一区二区 | 春药玩弄少妇高潮吼叫 | 亚洲av中文无码字幕色最新 | 精品人妻少妇一区二区 | 最美女人体内射精一区二区 | 日本一卡二卡不卡视频查询 | 乱VODAFONEWIFI熟妇 | 久久精品黄| 极品少妇被弄得高潮不断 | 手机看片AV永久免费 | 国产激情无码一区二区 | 成人免费视频在线观看 | 亚洲国产精品无码久久98 | 亚洲欧美成人精品香蕉网 | av蓝导航精品导航 | 免费视频爱爱太爽了 | ww久久| 把腿张开老子臊烂你女人片 | 91sesese | 亚洲国产精品无码观看久久 | 车上震动a级作爱视频 | 久久男人AV资源网站无码 | 亚洲va在线∨a天堂va欧美va | 精品国产一区二区三区免费 | 久久久久国产一区二区三区 | 色窝窝免费播放视频在线 | 亚洲线精品一区二区三区影音先锋 | 欧美人与禽zozzo性伦交 | 大又大又粗又硬又爽少妇毛片 | 久久久久久久女国产乱让韩 | 中文在线8资源库 |